Tom Lloyd

机构：Pfizer (United States)

发表论文 7 篇 · 总被引 212 次 · h-index 6

代表论文

• Fuzzy control of disturbances in a wastewater treatment process (1997 · Water Research · 被引 70)
• Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918. (1996 · PubMed · 被引 68)
• Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens (1991 · Antimicrobial Agents and Chemotherapy · 被引 30)
• Simultaneous quantification of seven active metabolites of roxifiban in human plasma by LC/MS/MS in the presence of an interfering displacer at millimolar concentrations (2003 · Journal of Pharmaceutical and Biomedical Analysis · 被引 15)
• Effect of Alosetron (a New 5‐HT3Receptor Antagonist) on the Pharmacokinetics of Haloperidol in Schizophrenic Patients (1995 · The Journal of Clinical Pharmacology · 被引 15)
• Trace LC/MS/MS quantitation of 17β‐estradiol as a biomarker for selective estrogen receptor modulator activity in the rat brain (2009 · Journal of Mass Spectrometry · 被引 14)